Literature DB >> 8348571

Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat.

H Schunkert1, S S Tang, S E Litwin, D Diamant, G Riegger, V J Dzau, J R Ingelfinger.   

Abstract

OBJECTIVE: Activation of the intrarenal renin-angiotensin system may contribute to the pathophysiology of heart failure by accelerating the generation of angiotensin II at local sites within the kidneys. Activation of the local intrarenal renin-angiotensin system occurs in rats and with mild heart failure. The aim of the present study was to examine components of the circulating as well as the intrarenal renin-angiotensin system in rats with severe heart failure.
METHODS: Six weeks after experimental myocardial infarction (heart failure, HF; n = 8) or sham operation (control, C; n = 6), haemodynamics and the circulating and intrarenal components of the renin-angiotensin system were studied.
RESULTS: HF rats were characterised by large infarctions (scar tissue > 40% of the left ventricular circumference). In comparison to sham operated controls, large myocardial infarctions resulted in severe heart failure with decreased systolic [108(SEM 3) mm Hg v 132(3) in C; p < 0.001] and diastolic arterial blood pressure [83(3) mm Hg v 95(2) in C; p < 0.05], decreased left ventricular systolic pressure [109(3) mm Hg v 132(3) in C; p < 0.005] and increased left ventricular end diastolic pressure [27(2) mm Hg v 5(1) in C; p < 0.0001]. In rats with severe heart failure, the circulating renin-angiotensin system was activated, with an increase in plasma renin activity (3.5-fold, p < 0.05) and plasma angiotensin II concentration (threefold, p < 0.01). In parallel, the intrarenal renin-angiotensin system was activated in severe heart failure. Increases occurred in renal renin mRNA level (1.7-fold, p < 0.01), renal angiotensinogen mRNA level (1.8-fold, p < 0.05), and renal angiotensin II concentration (twofold, p < 0.05) compared to C. Intrarenal angiotensin II concentrations exceeded plasma levels by a factor of 50 and were positively correlated with renal angiotensinogen mRNA levels (r = 0.874, p < 0.001), suggesting that local synthesis is the major source of angiotensin II found in the kidney.
CONCLUSIONS: The intrarenal renin-angiotensin system may be selectively activated in mild heart failure, while both circulating and intrarenal renin-angiotensin systems are induced as the extent of left ventricular function worsens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348571     DOI: 10.1093/cvr/27.5.731

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

1.  Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.

Authors:  S E Litwin; S E Katz; J P Morgan; P S Douglas
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure.

Authors:  Branko Braam; William A Cupples; Jaap A Joles; Carlo Gaillard
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

3.  Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats.

Authors:  Huiyin Tu; Libin Zhang; Thai P Tran; Robert L Muelleman; Yu-Long Li
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

Review 4.  Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure.

Authors:  S R Holmer; H Schunkert
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

5.  Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.

Authors:  M Brink; J Wellen; P Delafontaine
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure.

Authors:  Takehito Kemuriyama; Megumi Tandai-Hiruma; Kazuo Kato; Hiroyuki Ohta; Satoshi Maruyama; Yoshiaki Sato; Yasuhiro Nishida
Journal:  J Physiol Sci       Date:  2009-03-28       Impact factor: 2.781

7.  High levels of circulating angiotensin II shift the open-loop baroreflex control of splanchnic sympathetic nerve activity, heart rate and arterial pressure in anesthetized rats.

Authors:  Toru Kawada; Atsunori Kamiya; Meihua Li; Shuji Shimizu; Kazunori Uemura; Hiromi Yamamoto; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2009-08-18       Impact factor: 2.781

Review 8.  Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.

Authors:  W Linz; G Wiemer; J Schaper; R Zimmermann; K Nagasawa; P Gohlke; T Unger; B A Schölkens
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

9.  Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction.

Authors:  Zhu-zhi Wen; Mu-yan Cai; Zun Mai; Dong-mei Jin; Yang-xin Chen; Hui Huang; Deng-feng Geng; Jing-feng Wang
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

10.  Circulating angiotensin II deteriorates left ventricular function with sympathoexcitation via brain angiotensin II receptor.

Authors:  Keisuke Shinohara; Takuya Kishi; Yoshitaka Hirooka; Kenji Sunagawa
Journal:  Physiol Rep       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.